Schrödinger Signs a Two-Year Research Collaboration with MD Anderson to Advance its WEE1 Program
Shots: MD Anderson to receive payments based on the development and commercialization of Schrödinger’s WEE1 inhibitor compounds. Schrödinger to provide research funding & will unite with researchers […]